Periostin: A novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients

Lupus

Volumn 24, Issue 8, 2015, Pages 835-845

  Wantanasiri, P ^a   Satirapoj, B ^b   Charoenpitakchai, M ^b   Aramwit, P ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

activity index; chronicity index; lupus nephritis; Periostin; renal function

Indexed keywords

BIOLOGICAL MARKER; CREATININE; NITROGEN; TRANSCRIPTION FACTOR RUNX2; UREA; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ADULT; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PATHOLOGIST; PRIORITY JOURNAL; SCORING SYSTEM; SLEDAI; UREA NITROGEN BLOOD LEVEL; AGED; BLOOD; FIBROSIS; KIDNEY; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BLOOD UREA NITROGEN; CELL ADHESION MOLECULES; CREATININE; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84930896120     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314566634     Document Type: Article

References (34)

1. Nowling T, Gilkeson G. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011 ; 13: 250-250
2. Bob F, Gluhovschi G. Process of fibrogenesis in glomerular nephropathies. TMJ. 2004 ; 54: 297-307
3. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 ; 64: 797-808
4. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. New Engl J Med. 2006 ; 354: 2473-2483
5. Frangogiannis NG. Biomarkers: Hopes and challenges in the path from discovery to clinical practice. Transl Res. 2012 ; 159: 197-204
6. Satirapoj B. Novel biomarkers in diabetic and chronic kidney disease. Royal Thai Army Med J. 2010 ; 16: 7-12
7. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: Diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006 ; 33: 1563-1569
8. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: Cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993 ; 294 (Pt 1). 271-278
9. Stanton LW, Garrard LJ, Damm D, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res. 2000 ; 86: 939-945
10. Takayama G, Arima K, Kanaji T, et al. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006 ; 118: 98-104
11. Shimazaki M, Nakamura K, Kii I, et al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med. 2008 ; 205: 295-303
12. Stansfield WE, Andersen NM, Tang RH, Selzman CH. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg. 2009 ; 88: 1916-1921
13. Hakuno D, Kimura N, Yoshioka M, et al. Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest. 2010 ; 120: 2292-2306
14. Ito T, Suzuki A, Imai E, et al. Tornado extraction: A method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidney. Kidney Int. 2002 ; 62: 763-769
15. Sorocos K, Kostoulias X, Cullen-McEwen L, Hart AH, Bertram JF, Caruana G. Expression patterns and roles of periostin during kidney and ureter development. J Urol. 2011 ; 186: 1537-1544
16. Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: Novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant. 2012 ; 27: 2702-2711
17. Guerrot D, Dussaule JC, Mael-Ainin M, et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012 ; 7: e31974 - e31974
18. Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011 ; 179: 1756-1767
19. Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc. 2014 ; 46: 135-140
20. Parichatikanond P, Chawanasuntorapoj R, Shayakul C, et al. An analysis of 3,555 cases of renal biopsy in Thailand. J Med Assoc Thai. 2006 ; 89: S106 - S111
21. Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int. 1984 ; 25: 689-695
22. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 ; 11: 155-168
23. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 ; 15: 241-250
24. Satirapoj B, Nast CC, Adler SG. Novel insights into the relationship between glomerular pathology and progressive kidney disease. Adv Chronic Kidney Dis. 2012 ; 19: 93-100
25. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 2004 ; 15: 1-12
26. Ravinal RC, Costa RS, Coimbra TM, et al. Classes, activity and chronicity indices, and alpha-smooth muscle actin expression as prognostic parameters in lupus nephritis outcome. Lupus. 2002 ; 11: 82-87
27. Makni K, Jarraya F, Khabir A, et al. Renal alpha-smooth muscle actin: A new prognostic factor for lupus nephritis. Nephrology (Carlton). 2009 ; 14: 499-505
28. Bob FR, Gluhovschi G, Herman D, et al. Histological, immunohistochemical and biological data in assessing interstitial fibrosis in patients with chronic glomerulonephritis. Acta Histochemica. 2008 ; 110: 196-203
29. Ward C, Robertson H, Forrest IA, et al. Hypothesis: Epithelial-to-mesenchymal transition is a common cause of chronic allograft failure. Transplant Proc. 2005 ; 37: 977-980
30. Zusen X, Yanlei C. Determination of serum interleukin-13 and nerve growth factor in patients with systemic lupus erythematosus and clinical significance. J Huazhong Univ Sci Technolog Med Sci. 2005 ; 25: 360-361
31. Morimoto S, Tokano Y, Kaneko H, Nozawa K, Amano H, Hashimoto H. The increased interleukin-13 in patients with systemic lupus erythematosus: Relations to other Thl-, Th2-related cytokines and clinical findings. Autoimmunity. 2001 ; 34: 19-25
32. Chen X, Zhang Z, Jiang L, Ye F, Wang j, Wu P. Elevated interleukin-13 in patients with active lupus nephritis. Chin Med J (Engl). 2001 ; 114: 1022-1025
33. Blanchard C, Mingler MK, McBride M, et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008 ; 1: 289-296
34. Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007 ; 104: 15858-15863